WebMainz, Germany. Mainz Biomed ( NASDAQ: MYNZ) is located just west of Frankfurt in a world-renowned community for advanced DNA & Pharmaceutical research, including the home of vaccine maker BioNTech SE. The TÜV Rheinland certifies that Mainz Biomed manufactures ColoAlert according to DIN EN ISO 13485. Click here to view certificate. Web21 hours ago · The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mainz Biomed B.V. with a $18.00 average price target, which is a …
Did you know?
WebMar 21, 2024 · Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23 . BERKELEY, US – MAINZ, Germany – March 21, 2024 — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced that Bill Caragol, the … WebApr 10, 2024 · Mainz Biomed macht 2024 einen Umsatz von 0,53 Millionen Dollar, im Vorjahr waren es 0,58 Millionen Dollar. Die F&E-Ausgaben steigen von 0,47 Millionen …
WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular ... WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, US – MAINZ, Germany – April 10, 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today financial results for the fiscal year ended December 31, 2024.
WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, US - MAINZ, Germany - April 10, 2024 - Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the … WebApr 10, 2024 · ColoAlert Revenue Increases 130% Year over Year. Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE …
WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. …
WebMar 15, 2024 · BERKELEY, US – MAINZ, Germany – [March 15, 2024] — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a partnership with Dr Staber & Kollegen GmbH (Labor Staber) as part of its growing network of laboratories ... sick artistWebApr 11, 2024 · 17.34 (+177.44%) Earnings Date. May 1, 2024. According to 9 analysts, the average rating for MYNZ stock is "Buy." The 12-month stock price forecast is $17.34, … the phenix at 4 mile apartmentsWebApr 10, 2024 · Mainz Biomed B.V. GAAP EPS of -$1.86, revenue of $0.53M Apr. 10, 2024 7:09 AM ET Mainz Biomed N.V. (MYNZ) By: Deepa Sarvaiya , SA News Editor Mainz Biomed B.V. press release ( NASDAQ: MYNZ ): FY ... the phenix at infinity parkWebApr 11, 2024 · 17.34 (+177.44%) Earnings Date. May 1, 2024. According to 9 analysts, the average rating for MYNZ stock is "Buy." The 12-month stock price forecast is $17.34, which is an increase of 177.44% from the latest price. the phene south kensingtonWebFeb 21, 2024 · Anne Hennecke/Caroline Bergmann. +49 211 529252 20. [email protected]. In the US: Spectrum Science. Melissa Laverty/Valerie Enes. +1 540 272 6465. [email protected]. For investor ... sick as30-ebm314i220c00WebApr 10, 2024 · Mainz Biomed B.V. GAAP EPS of -$1.86, revenue of $0.53M Apr. 10, 2024 7:09 AM ET Mainz Biomed N.V. (MYNZ) By: Deepa Sarvaiya , SA News Editor Mainz … the phene kings roadWebMar 8, 2024 · Gastro Update 2024. #1 Friday and Saturday, March 10-11, 2024. Rheingoldhalle; Mainz, Germany. #2 Friday and Saturday, March 24-25, 2024. Berlin Congress Center; Berlin, Germany. Patient Education ... sickarts.com